HUMANOVA Revenue and Competitors
Estimated Revenue & Valuation
- HUMANOVA's estimated annual revenue is currently $4.1M per year.
- HUMANOVA's estimated revenue per employee is $112,000
Employee Data
- HUMANOVA has 37 Employees.
- HUMANOVA grew their employee count by 3% last year.
HUMANOVA's People
Name | Title | Email/Phone |
---|---|---|
1 | Konsult | Reveal Email/Phone |
2 | Kommunikationsansvarig | Reveal Email/Phone |
3 | Kommunikationsansvarig | Reveal Email/Phone |
4 | Kontorschef | Reveal Email/Phone |
HUMANOVA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $223.4M | 1116 | 5% | $65M | N/A |
#2 | $13.6M | 97 | 2% | $23.1M | N/A |
#3 | $1.1M | 13 | N/A | N/A | N/A |
#4 | $87.5M | 492 | -4% | $206M | N/A |
#5 | $41.9M | 272 | 18% | N/A | N/A |
#6 | $53.4M | 305 | 22% | N/A | N/A |
#7 | $55.8M | 314 | -5% | $102.6M | N/A |
#8 | $13.6M | 97 | 13% | N/A | N/A |
#9 | $0.2M | 3 | N/A | N/A | N/A |
#10 | $2.8M | 29 | N/A | N/A | N/A |
What Is HUMANOVA?
N/A
Total Funding
37
Number of Employees
$4.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HUMANOVA News
2022-04-13 - Michigan Judge Declares She Will Preside Over Planned Parenthood Case
Despite Her Prior Representation and Donations
Preimplantation loss of fertilized human ova: estimating the unobservable. Human reproduction (Oxford, England) 35.4 (2020): 743-750.
2022-04-13 - Patenting Stem Related Inventions In India - Intellectual ...
Pluripotent stem cells are used, processed, and human embryonic stem cell lines are created in the HESCRs. Human embryos are not the same thing...
2022-03-22 - One futuristic alien technology could confirm the existence of advanced
life in space
As Matloff summarizes it, A Von Neumann probe could carry fertilized human ova to be raised robotically and populate in-space habitats...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.4M | 37 | -10% | N/A |
#2 | $6.7M | 37 | 28% | N/A |
#3 | $4.4M | 37 | -12% | N/A |
#4 | $7.5M | 37 | 12% | N/A |
#5 | $4.4M | 37 | 3% | N/A |